Cargando...

Second-line afatinib administration in an elderly patient with squamous cell carcinoma

INTRODUCTION: The majority of cases of lung cancer are still diagnosed at a late stage. At this stage, palliative therapeutic options including nonspecific cytotoxic drugs, targeted therapy, or immunotherapy can be utilized. In 2016, immunotherapy was approved in Europe for squamous cell carcinoma a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Clin Risk Manag
Main Authors: Hohenforst-Schmidt, Wolfgang, Zarogoulidis, Paul, Steinheimer, Michael, Benhassen, Naim, Sardeli, Chrysanthi, Stalikas, Nikos, Toitou, Melpomeni, Huang, Haidong
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5367451/
https://ncbi.nlm.nih.gov/pubmed/28356747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S130816
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!